U.S. market Closed. Opens in 2 hours 39 minutes

SXTC | China SXT Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-31
Revenue1.93M1.97M2.60M4.78M5.16M7.01M7.02M4.88M3.72M
Cost of Revenue1.37M1.55M1.35M1.94M2.46M2.40M3.62M2.57M2.92M
Gross Profit553.97K426.27K1.25M2.84M2.70M4.61M3.40M2.31M793.99K
Operating Expenses3.07M6.03M6.44M5.04M4.04M2.84M1.77M709.82K584.85K
Selling, General & Admin3.07M6.03M6.44M5.04M4.04M2.84M1.77M709.82K584.85K
Research & DevelopmentN/AN/AN/AN/AN/AN/AN/AN/AN/A
Other Operating ExpensesN/A149.51K-181.58K871.65K-73.77K27.14K-3.80K18.40KN/A
Operating Income-2.52M-5.61M-5.19M-2.20M4.28M1.77M1.63M1.60M209.14K
Other Expenses / Income-583.32K-327.26K-218.28K-743.79K-9.05M21.97K-4.58K-21.99K-20.41K
Before Tax Income-3.10M-5.93M-5.41M-2.94M-10.39M1.79M1.63M1.58M188.72K
Income Tax ExpensesN/A476.78K328.15K-192.68K-101.72K252.23K440.10K395.05K47.18K
Net Income-3.10M-5.93M-5.74M-2.75M-10.29M1.54M1.19M1.19M141.54K
Interest Expenses544.28K476.78K218.28K1.62M3.35M5.17K779.00N/AN/A
Basic Shares Outstanding867.42K266.97K41.59K28.78K12.36K10.28KN/AN/AN/A
Diluted Shares Outstanding867.42K266.97K41.59K28.78K12.36K10.28KN/AN/AN/A
EBITDA-2.35M-5.21M-5.05M-1.85M-1.01M1.95M1.76M1.70M298.11K
EBITDA Margin-121.91%-264.13%-194.11%-38.76%-19.55%27.82%25.10%34.85%8.02%
EBIT-2.55M-4.98M-5.19M-1.33M-7.04M1.80M1.63M1.58M188.72K
EBIT Margin-132.45%-252.64%-199.43%-27.74%-136.39%25.62%23.20%32.37%5.08%
Financial Year End2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙